Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects
Clinical trial NCT05657834 · COMPLETED
Trial details
- NCT number
- NCT05657834
- Sponsor
- Sagimet Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2022-12-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.